Keyphrases
Natural Killer Cells
100%
Tumor
35%
NKT Cells
32%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
29%
NF-B
27%
NKG2D
27%
T Cells
23%
Antimetastatic Effect
22%
Tumor Cells
20%
Cancer Cells
19%
Breast Cancer Cells
19%
Cancer Immunotherapy
18%
Interferon-α (IFN-α)
17%
Tumor Metastasis
16%
Perforin
15%
Liver
15%
Tumor Immunity
14%
Apoptosis
14%
Metastatic Potential
14%
Cancer Metastasis
14%
Interleukin-21 (IL-21)
13%
Tumor Growth
13%
CD27
13%
GalCer
12%
α-galactosylceramide (α-GalCer)
12%
Melanoma
12%
Cytotoxicity
12%
Metastasis
12%
Liver Metastasis
11%
Tumor Rejection
11%
Non-small Cell Lung Cancer (NSCLC)
11%
In Cancer
11%
Effector Function
10%
Antimetastatic
10%
Immune Surveillance
10%
Antitumor Effect
10%
Interleukin-12 (IL-12)
10%
Cell-mediated
9%
Cell Death
9%
Macrophages
9%
Immune Response
9%
Breast Cancer
9%
Cell-to-cell
8%
Lung Metastasis
8%
Molecular Mechanism
8%
CD1d
8%
Antitumor Activity
8%
Immune System
8%
Gene-deficient Mice
7%
Hirsutine
7%
Immunology and Microbiology
Natural Killer Cell
98%
Natural Killer T Cell
40%
T Cell
31%
NKG2D
23%
Cancer Cell
22%
Cytokine
21%
Immunosurveillance
19%
Cytotoxicity
19%
Tumor Cell
17%
interferon
15%
Perforin
15%
Immune Response
14%
Immunity
13%
TNF related apoptosis inducing ligand
13%
Immunology
12%
Antineoplastic Activity
12%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
11%
Tumor Rejection
11%
Cell Maturation
10%
T Cell Receptor
10%
Maturation
9%
Tumor Immunity
9%
Immunotherapy
8%
Cancer Immunotherapy
8%
Interleukin 4
8%
MHC Class I
6%
Dendritic Cell
6%
Bioluminescence
6%
Antiinflammatory Activity
6%
Cytotoxic T-Cell
6%
Angiogenesis
6%
Homeostasis
6%
Major Histocompatibility Complex
6%
Immune System
5%
Cytotoxic T Cell
5%
Cell Activation
5%
Thalidomide
5%
Mast Cell
5%
Kaempferia
5%
T-Helper Cell
5%
Cytokine Production
5%
Lymphocyte
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
46%
Malignant Neoplasm
39%
Metastasis
30%
Breast Cancer
30%
Lung Cancer
17%
Cytokine
17%
Melanoma
16%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
12%
Cytotoxicity
12%
Non Small Cell Lung Cancer
12%
Galactosylceramide
11%
Inflammation
11%
Kaempferia
10%
Metastasis Potential
10%
Anti-Inflammatory Drug
10%
Interferon
9%
Lung Metastasis
9%
Immunotherapy
9%
Liver Metastasis
8%
Interleukin 6
7%
Hirsutine
7%
Diterpenoid
7%
Antitumor Activity
7%
Epidermal Growth Factor Receptor
7%
Perforin
7%
Cancer Growth
7%
Phytochemical
7%
Natural Product
6%
Receptor
6%
Carcinoma
6%
Carcinogenesis
6%
Nuclear Factor
6%
Kampo Medicine (Drug)
5%
Cancer Model
5%
Antiinflammatory Activity
5%
Paclitaxel
5%
Infection
5%
Luciferase
5%
Anticarcinogen
5%
Thalidomide
5%
Alkadiene
5%
SARS Coronavirus
5%
Shi Quan Da Bu Tang
5%
Morus Alba
5%
Alternative Complement Pathway C3 C5 Convertase
5%
